Microsurgical Robotic System Top Companies-Recent Developments, Business Strategy, Deal Strategy, Patent Strategy, Benchmarking and Management Outlook

Date : November 2024

Microsurgical Robotic System Market Size Analysis and Top Companies

The global microsurgical robotic system market size is estimated to hit around USD 4.73 billion by 2033, increasing from USD 1.43 billion in 2023 with a CAGR of 12.49% from 2023 to 2033. The top companies operating in the microsurgical robotic system are Intuitive Surgical, Inc., Medtronic plc., Stryker Corporation, Zimmer Biomet Holdings, Inc., Accuray Incorporated, Smith & Nephew plc., TransEnterix Surgical, Inc., Renishaw plc., Medrobotics Corporation, Titan Medical Inc., Auris Health, Inc., Verb Surgical Inc. (a joint venture between Alphabet Inc.'s Verily and Johnson & Johnson), Microsure, MST Medical Surgery Technologies Ltd., Synaptive Medical Inc., and Others.

Market Report Coverage

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 12.49%
Market Size in 2023 USD 1.43 Billion
Market Size in 2024 USD 1.61 Billion
Market Size by 2033 USD 4.73 Billion
Largest Market Asia Pacific
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered Application, End-use, and Region
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Microsurgical Robotic System Key Players

  • Intuitive Surgical, Inc.
  • Medtronic plc.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Accuray Incorporated
  • Smith & Nephew plc.
  • TransEnterix Surgical, Inc.
  • Renishaw plc.
  • Medrobotics Corporation
  • Titan Medical Inc.
  • Auris Health, Inc.
  • Verb Surgical Inc. (a joint venture between Alphabet Inc.'s Verily and Johnson & Johnson)
  • Microsure
  • MST Medical Surgery Technologies Ltd.
  • Synaptive Medical Inc.

Recent Developments

  • In 2022, BGS Beta-Gamma-Service GmbH & Co. KG responded to the growing demand for sterilization services in biotechnology, medicine, and diagnostics by expanding its laboratory in Wiehl. This expansion aimed to cater to the specific needs of sectors relying on radiation cross-linking processes.
  • Similarly, Sterigenics expanded its electron beam facility in Columbia City, Indiana, in 2022. This facility plays a crucial role in providing E-beam sterilization services, particularly for medical devices and drug products, emphasizing its commitment to ensuring the safety and integrity of these critical healthcare items.

We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344